U.S. Biotech Stock News

If you are asking yourself whether Capital One Financial is fairly priced today or not, you are in the right place to make sense of the numbers before you act. The stock last closed at US$255.68, with returns of 5.5% over 7 days, 10.8% over 30 days, 3.1% year to date, 43.7% over 1 year and 144.5% over 5 years, which naturally raises questions about how much of this performance is already reflected in the share price. Recent coverage has focused on how established lenders like Capital One...

In recent months, multiple law firms have filed securities class action lawsuits against Integer Holdings, alleging that the company made false and misleading statements about its competitive position and growth prospects in the electrophysiology device market between July 25, 2024 and October 22, 2025. This wave of litigation raises questions about the reliability of Integer’s prior disclosures on a market segment that had been positioned as a long-term growth driver. Next, we’ll examine...

Without a specific news headline driving attention today, Universal (UVV) still attracts interest as a long-standing agriproducts supplier. Shares last closed at $54.26 and the company has a reported value score of 4. See our latest analysis for Universal. The recent 1-day share price return of 2.13% sits alongside a steady year-to-date share price return of 3.20%, while the 1-year total shareholder return of 11.09% and 5-year total shareholder return of 37.20% indicate gradually building...

Adaptive Biotechnologies (ADPT) is back in focus after announcing two non-exclusive collaborations with Pfizer on T-cell receptor discovery and immune data licensing, as well as a new Series A financing round for its Digital Biotechnologies subsidiary. See our latest analysis for Adaptive Biotechnologies. At a share price of $15.96, Adaptive Biotechnologies has seen a 30 day share price return of 7.40% and a 1 year total shareholder return of 138.56%. Recent collaborations and financing news...

Regulatory catalysts and pipeline progress put MannKind (MNKD) in focus MannKind (MNKD) recently outlined a series of 2026 growth drivers, centering on upcoming FDA decisions for Afrezza and FUROSCIX ReadyFlow, as well as updates across several clinical and preclinical respiratory programs. See our latest analysis for MannKind. The recent update on Afrezza, FUROSCIX ReadyFlow and the broader respiratory pipeline comes as MannKind’s share price sits at US$6.01, with a 90 day share price return...

AllianceBernstein Holding (AB) has drawn fresh attention after appointing Onur Erzan as President, expanding his remit across business transformation, distribution and new product lines such as active ETFs and insurance asset management. See our latest analysis for AllianceBernstein Holding. The latest leadership change comes as AllianceBernstein Holding’s share price, at about US$38.40, has seen a 30 day share price return decline of 5.4%, while the 1 year total shareholder return of 13.8%...

Recently, Travel + Leisure Co. announced a lower interest rate on its 2024 Term Loan B Facility while maintaining the existing maturity, alongside active share repurchases and ongoing dividend increases that underscore its current capital allocation priorities. These moves coincided with fresh analyst attention, including upgraded and new coverage, highlighting how the company’s balance sheet management and shareholder return policy are influencing how the market views its business model...

What Murphy Oil (MUR) investors may be watching now Murphy Oil (MUR) has posted mixed recent returns, with a roughly flat move over the past month but a gain over the past 3 months, putting the stock back on some investors’ radar. See our latest analysis for Murphy Oil. The recent 9.43% 1 day share price return and 22.30% 90 day share price return at around $32.74 sit against a more modest 5.14% 1 year total shareholder return and a weaker 3 year total shareholder return, suggesting momentum...

Mizuho’s downgrade of Roper Technologies (ROP) and its reduced rating outlook have put fresh attention on the stock, after the move coincided with a share price decline and mixed signals from other analyst and short interest data. See our latest analysis for Roper Technologies. The downgrade lands on top of a softer trend, with the 90 day share price return of Roper Technologies at a 14.64% decline and the 1 year total shareholder return at a 14.30% decline. This suggests recent momentum has...

Investors may be wondering if Kinsale Capital Group at around US$411 a share still offers value, or if most of the easy gains are already behind it. The stock has recently seen a 5.1% move over the last 7 days, 10.5% over 30 days and 4.8% year to date, while the 1 year return sits at a 2.4% decline and the 3 year and 5 year returns are 42.9% and 107.0% respectively. These price moves come as investors continue to track Kinsale Capital Group's position in the specialty insurance space and...

In recent days, EQT has come under pressure as weaker U.S. natural gas prices, driven by milder winter weather forecasts, weighed on producer margins and investor sentiment. Despite this softness in the commodity backdrop and a pause after a multi-month rally, analysts remain broadly constructive on EQT’s longer-term fundamentals and cash flow focus. Next, we’ll examine how this weather-driven softness in natural gas prices may influence EQT’s existing investment narrative and risk-reward...

On 8 January 2026, GreyOrange and Zebra Technologies announced a partnership that combines Zebra’s SmartLens overhead RFID system with GreyOrange’s gStore platform to deliver near-real-time, item-level inventory visibility and automated in-store tasking for retailers. An early rollout at a national fashion retailer reportedly achieved on-shelf availability of up to 98%, highlighting how the solution could reduce manual counts, cut order cancellations, and boost store labor efficiency while...

Array Technologies (ARRY) has caught investor attention after recent share price swings, with the stock now around US$8.85. That moves against a backdrop of mixed short term returns and a longer, more challenging track record. See our latest analysis for Array Technologies. The recent pullback, including a 1 day share price return of a 2.21% decline and a 7 day share price return of a 4.01% decline, comes after a 1 year total shareholder return of 35.53%. This suggests earlier positive...

If you are wondering whether RadNet's recent share price puts it "on sale" or already pricing in a lot of optimism, you are in the right place. RadNet closed at US$78.38, with returns of 9.9% over the last 7 days, 3.3% over 30 days, 10.5% year to date, 8.5% over 1 year, and a very large gain over 3 years that is close to 3x, plus 273.2% over 5 years. Recent coverage around RadNet has focused on the business more broadly, giving investors extra context for the current share price and those...

Agree Realty (ADC) is back in focus after reporting about US$1.55b of real estate investments in 2025 and issuing its highest initial investment guidance yet for 2026, centered on retail net lease properties. See our latest analysis for Agree Realty. Despite the strong 2025 investment activity and higher 2026 guidance, Agree Realty’s recent share price performance has been muted, with a slightly negative year to date share price return. The 5 year total shareholder return of 40.39% points to...

In its latest quarterly update, Royalty Pharma reported year-on-year revenue growth of 7.9% that came in 2.6% below analyst expectations while simultaneously raising full-year guidance and reiterating confidence in achieving another year of double-digit top-line growth. This combination of a short-term revenue miss and a more optimistic full-year outlook, set against both technological tailwinds like precision medicine and AI and headwinds such as pricing pressure and patent cliffs, sharpens...

Lantheus Holdings has completed the sale of its SPECT business unit and reported progress in neurodegenerative imaging, including past CTAD 2025 data presentations and anticipated 2026 regulatory decisions for new beta-amyloid and tau agents, while planning a reformulated Pylarify launch to address pricing pressures. This repositioning concentrates capital and management attention on higher-growth imaging platforms, potentially altering how investors view the balance between product...

Earlier this week, Shift4 Payments, Inc. announced that its subsidiary repriced and refinanced US$997,500,000 of senior secured term loans, cutting interest margins on both SOFR‑based and base‑rate borrowings under its first lien credit agreement. The move keeps key loan terms intact while lowering financing costs, signaling management’s focus on balance sheet efficiency alongside its ongoing growth initiatives. We’ll now explore how this repricing of nearly US$1.00 billion in term loans...

MSC Industrial Direct (MSM) opened fiscal Q1 2026 with total revenue of US$965.7 million and basic EPS of US$0.93, alongside net income excluding extra items of US$51.8 million, providing an updated view of how its margins are holding up. Over recent quarters, the company has reported revenue of US$952.3 million in Q4 2024, US$928.5 million in Q1 2025, and US$965.7 million in Q1 2026. EPS over the same periods was US$0.99, then US$0.83, and now US$0.93, which puts the latest results in...

Some investors are considering whether Toro's current share price aligns with its underlying worth, or if recent market interest has pushed it away from that level. Toro's stock has recently traded at US$87.87, with returns of 11.6% over the last 7 days, 26.1% over 30 days, 9.6% year to date, 13.2% over 1 year, but declines of 20.0% over 3 years and 5.3% over 5 years. Recent attention on Toro has focused on how its long-term share performance compares with shorter-term gains, which has put...

If you are wondering whether General Motors stock still offers value at current levels, you are not alone. This article focuses squarely on that question. GM shares last closed at US$85.13, with returns of 4.7% over 7 days, 10.3% over 30 days, 5.1% year to date, 68.7% over 1 year and 129.2% over 3 years, compared to 71.2% over 5 years. Recent headlines around General Motors have focused on its ongoing transition toward electric and software enabled vehicles, along with industry wide...

Wayland exit puts HNI’s manufacturing footprint in focus HNI (HNI) has drawn fresh investor attention after announcing plans to exit its Wayland, New York, manufacturing facility by 2027. The company will consolidate production into other North American plants to pursue efficiency and cost savings. See our latest analysis for HNI. The Wayland exit comes as HNI’s 7-day share price return of 3.83% and 30-day share price return of 7.20% suggest near term momentum, while its 1-year total...

Prologis (PLD) is back in focus after new data flagged it as the REIT sector’s largest projected dividend payer for 2026, with an expected payout of about $4.3b and approximately 10% year-on-year growth. See our latest analysis for Prologis. Recent dividend headlines arrive as Prologis’ share price, now at $128.39, has logged a 15.43% 90 day share price return, while its 1 year total shareholder return of 26.03% and 5 year total shareholder return of 54.65% point to momentum that has been...

If you are wondering whether CubeSmart's current share price lines up with its underlying worth, you are not alone. This article is built to help you frame that question clearly. The stock most recently closed at US$37.06, with returns of 2.8% over 7 days, 4.2% over 30 days, 4.7% year to date, while the last 1 year shows a 5.5% decline and the 5 year return sits at 35.7%. Recent coverage of CubeSmart has focused on its position in the self storage real estate space and how investors are...